Elimination of counterfeit and substandard drugs eyed

Published: 2003-01-07 07:00:00

Updated: 2003-01-07 07:00:00

The Korea Food and Drug Administration (KFDA) announced its 2003 pharmaceutical affairs inspection program, the salient points of which are as follows:

- Each regional KFDA is scheduled to inspect counterfeit and substandard drugs (e.g., unlawfully smuggled or produced drugs, drugs mixed with ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK